Design Therapeutics, Inc. (DSGN) › Shareholders' EquityDesign Therapeutics, Inc. (DSGN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$3.64M2020: -$11.31M2021: $382.13M2022: $327.31M2023: $277.69M2024: $242.10M2025: $212.50M$212.50M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$212.50M-12.2%2024$242.10M-12.8%2023$277.69M-15.2%2022$327.31M-14.3%2021$382.13M+3477.2%2020-$11.31M-210.7%2019-$3.64M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share